A carregar...

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer

BACKGROUND: There has been considerable development in the treatment of advanced prostate cancer over the last decade. A number of agents, including docetaxel, cabazitaxel, abiraterone acetate, enzalutamide and sipuleucel‐T, have been reported to improve outcomes in men with castration‐resistant dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Sathianathen, Niranjan J, Philippou, Yiannis A, Kuntz, Gretchen M, Konety, Badrinath R, Gupta, Shilpa, Lamb, Alastair D, Dahm, Philipp
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2018
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516883/
https://ncbi.nlm.nih.gov/pubmed/30320443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012816.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!